Visilizumab Antibody
Visilizumab is a humanized IgG2 monoclonal antibody targeting CD3 on T-cells with minimized Fc binding to reduce activation-induced cytotoxicity. It modulates T-cell function and has been investigated in preclinical and clinical studies for immune-mediated conditions like ulcerative colitis and Crohn's disease.
Product Specifications
Product Name Alternative
Anti-Human CD3E Recombinant Antibody, HuM291
Target
Apoptosis, Others
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology
Concentration
5.16 mg/mL
Purity
97.60% (May vary between batches)
Molecular Weight
144.64 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog